ALT – altimmune, inc. (US:NASDAQ)
Stock Stats
News
Altimmune (ALT) is now covered by Truist Financial Corporation. They set a "buy" rating and a $12.00 price target on the stock.
Altimmune (ALT) had its price target raised by HC Wainwright from $12.00 to $25.00. They now have a "buy" rating on the stock.
Altimmune Touts Pemvidutide Progress, Targets MASH Phase 3 Start and Q3 AUD Readout at Barclays Chat [Yahoo! Finance]
Altimmune Details Pemvidutide MASH Path: Breakthrough Therapy, FDA Feedback, Phase 3 Next Up [Yahoo! Finance]
Altimmune (ALT) had its price target lowered by B. Riley Financial, Inc. from $18.00 to $13.00. They now have a "buy" rating on the stock.
Form ARS Altimmune, Inc. For: Dec 31
Form DEF 14A Altimmune, Inc. For: Apr 16
Form 4 Altimmune, Inc. For: Mar 06 Filed by: WEAVER GREGORY L
Form 4 Altimmune, Inc. For: Mar 06 Filed by: Durso Jerome Benedict
Form PRE 14A Altimmune, Inc. For: Apr 16
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.